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Abstract
Background and Purpose: 17-O-acetylacuminolide (AA), a diterpenoid labdane, was isolated for the first time from the
plant species Neouvaria foetida. The anti-inflammatory effects of this compound were studied both in vitro and in vivo.
Experimental Approach: Plant extracts were initially tested against LPS-stimulated release of tumor necrosis factor alpha
(TNF-a) from murine macrophages (RAW264.7 cells). Based on bioassay-guided fractionation, the active compound was
identified as AA. AA was tested for its ability to reduce nitric oxide (NO) production, and the inducible nitric oxide synthase
(iNOS) expression. The inhibition of a panel of inflammatory cytokines (TNF, IL-1b, IL-6, KC, and GM-CSF) by AA was assessed
at the expression and the mRNA levels. Moreover, the effect of AA on the translocation of the transcription factor nuclear
factor kappa B (NF-kB) was evaluated in LPS-stimulated RAW264.7 cells and in TNF-stimulated L929 cells. Subsequently, AA
was tested in the inhibitor of NF-kB kinase beta (IKKb) activity assay. Lastly, the anti-inflammatory activity of AA in vivo was
evaluated by testing TNF production in LPS-stimulated Balb/c mice.
Key Results: AA effectively inhibited TNF-a release with an IC50 of 2.7 mg/mL. Moreover, AA significantly inhibited both NO
production and iNOS expression. It significantly and dose-dependently inhibited TNF and IL-1b proteins and mRNA
expression; as well as IL-6 and KC proteins. Additionally, AA prevented the translocation of NF-kB in both cell lines;
suggesting that it is acting at a post receptor level. This was confirmed by AA’s ability to inhibit IKKb activity, a kinase
responsible for activating NF-kB, hence providing an insight on AA’s mechanism of action. Finally, AA significantly reduced
TNF production in vivo.
Conclusions and Implications: This study presents the potential utilization of this compound, as a lead for the development
of an anti-inflammatory drug.
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Introduction
Inflammation, a healing response of the body to various insults,
is a two edged sword. While it is typically recognized as a process
for the remission of diseases, the persistence of this process may
lead to various diseases associated with chronic inflammation
[1,2]; this includes arthritis, atherosclerosis, and even cancer
[3,4,5]. Due to the resistance of such diseases to conventional
treatments, as well as the side-effects of presently available anti-
inflammatory drugs, there is a pressing need for the development
of novel anti-inflammatory drugs. Natural products are a valuable
source of novel bioactive secondary metabolites [6]. Various
bioassays exist in which the anti-inflammatory activity of these
products can be evaluated [7].
Macrophages have been implicated in many of these assays, as
they are directly involved with the inflammatory response [8]. One
of the important roles of macrophages is the production of various
cytokines, reactive oxygen and nitrogen species, growth factors and
chemokines as a response to activation signals such as chemical
mediators, cytokines, and bacterial lipopolysaccharide (LPS) [9,10].
Although the bioactive molecules produced by macrophages have
valuable outcomes in inflammation, these molecules were also
shown to have unfavorable and damaging effects [11]. Hence the
modulation of these products provides a target for controlling
inflammatory diseases. Of particular importance is the production
of the cytokine tumor necrosis factor alpha (TNF-a) or (TNF).
TNF was shown to affect various biological processes inclu-
ding the regulation and the production of other cytokines [12]. By
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e15105
utilizing an in vitro bioassay in which TNF production can be
evaluated, compounds from natural products directed at inhibiting
this cytokine can be identified. In this study, the screening of a
library of Malaysian plants led to the isolation of the compound
17-O-Acetylacuminolide (AA) (Figure 1) from the plant Neouvaria
foetida. The compound, a diterpene labdane, was shown to inhibit
TNF production from murine macrophages. Terpenoids, a class of
secondary metabolites under which 17-O-acetylacuminolide falls,
are reported to have diverse biological activities [13]. The present
study investigated the potential anti-inflammatory activity of 17-O-
Acetylacuminolide in vitro and in vivo to evaluate its use as a
possible lead compound.
Methods
Ethics statement
Animal experiments were performed in accordance with the
guidelines for animal experimentation issued by the Animal Care
and Use Committee at the University of Malaya (Ethics Number:
FAR/11/03/2009/MA(R)).
Cell lines and Reagents
RAW264.7 and L929 murine cell lines were obtained from
American type culture collection (ATCC). Dulbecco’s Modified
Eagle Medium (DMEM) both with and without phenol red, phos-
phate buffered saline and Hanks’ balanced salt solution (HBSS), 3-
(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT),
Phosphate buffered saline (PBS) and Griess reagent were from
Invitrogen (Carlsbad, USA). Fetal bovine serum (FBS), LPS from
E.coli serotype 0111:B4, pentoxifillyne, aminoguanidine hydrochlo-
ride, curcumin, recombinant murine TNF-a, Dimethylsulfoxide
(DMSO), and sodium nitrite were obtained from Sigma (St Louis,
USA). Interferon gamma (IFNc) was from BD Biosciences (New
Jersey, USA). TNF-a ELISA kit was from eBioscience (San Diego,
USA). Procarta cytokine assay and Quantigene plex 2.0 assay kits
were from Panomics (Affymetrix) (Santa Clara, USA). NF-kB
translocation and iNOS Activation kits were from Cellomics
(Pittsburg, USA). K-LISATM IKKb-Inhibitor Screening Kit and
dexamethasone were from Calbiochem, Merck (Darmstadt,
Germany). All other chemicals and reagents used were of HPLC
grade.
Plant extraction
Plant material was obtained from the department of chemistry
herbarium, University of Malaya, Malaysia. Dried leaves (500 g)
of Neouvaria foetida (maingay ex Hk. f. et Th.) Airy shaw (specimen
voucher number: KL5513), were extracted in methanol for
48 hours at room temperature with shaking. The solvent was
dried by rotary evaporation under reduced pressure and at a
maximal temperature of 40uC. The extract was then freeze-dried
to yield crude methanol extract (45 g), which was stored at 220uC
until further use.
Chromatography and compound isolation
The crude extract was fractionated using reversed phase C18 flash
column chromatography into seven fractions (A–G). After pre-
conditioning with water, the crude extract was added to the column
and eluted using a step gradient of water and methanol as fol-
lows: Fraction A: MeOH:H2O (20:80); B: MeOH:H2O (30:70); C:
MeOH:H2O (40:60); D &E: MeOH:H2O (50:50); F: MeOH:H2O
(60:40); G: MeOH:H2O (100:0). The fractions were analyzed using
liquid chromatography mass spectrometry (LC-MS) (Shimadzu IT-
TOF) with AA being detected largely in fraction G (8.4 g).
Fraction G was then subjected to preparative high performance
liquid chromatography (HPLC) (Gilson GX-281/322 system)
using a Waters Novapak C18 column (256100 mm, 6 mm). The
extract was eluted at a flow rate of 12 mLmin21 over 60 mins.
The gradient started at 30% solvent (B) (acetonitrile with 0.1%
formic acid) and 70% solvent A (water with 0.1% formic acid) for
5 mins, then 30–37% (B) for 5 min. The gradient then changed
from 37% to 50% (B) over 45 minutes, followed by 50–100% (B)
for 5 minutes. Finally, there was an isocratic elution of 100% (B)
from 50 to 60 minutes. AA eluted at 36 min (Figure S1).
Final purification was achieved by re-crystallization from
methanol to yield AA. Purity was determined using proton nuclear
magnetic resonance (1H NMR) and Shimadzu LC-MS (Figures S2
and S3). For LC-MS analysis, the column used was BDS Hypersil
(C18, 5 mm, 4.66150 mm) and was maintained at 40uC, and the
injection volume was 20 ml, sample concentration was 1 mgmL21.
The compound was eluted at a flow rate of 1 mLmin21 over
30 mins. Forty five percent solvent B (acetonitrile with 0.1% formic
acid) flowed through the column with 55% solvent A (water with
0.1% formic acid) with a gradient of an increasing concentration of
(B), reaching 75% (B) over 25 minutes. Solvent B concentration
increased from 75–100% over one minute, then there was an
isocratic elution with 100% solvent (B) from 26–30 minutes. The
compound eluted at 10.35 minutes (Figure S3).
The identity and purity was also confirmed with 1H NMR using
a Lambda 400 MHz FT-NMR spectrometer in CDCl3 and d6-
dimethyl sulfoxide with all data being identical to that previously
reported for AA [14]. AA mass and UV spectra are as depicted in
(Figures S4, S5, S6). AA was dissolved in dimethyl sulfoxide
(DMSO) and diluted in DMEM or PBS before it was used for
testing its biological activity.
Cell culture
Cells were maintained in high glucose DMEM with 10% FBS
and no antibiotics, with passage every 2–3 days using standard
aseptic techniques. Cells from 70–90% confluent flasks with
.90% viability were seeded into 96-well culture plates at the
densities indicated below.
Figure 1. Chemical structure of 17-O-acetylacuminolide
[(12S)-17-acetoxy-8a,12-epoxy-16(R)-hydroxylabd-13(14)Z-en-
15,16-olide].
doi:10.1371/journal.pone.0015105.g001
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Cell viability and cytotoxicity
The viability of the cells was assessed using the MTT
colorimetric assay as described in [15] with some modifications.
RAW264.7 cells were either left untreated or were treated with AA
at the indicated doses. Following 4 hours incubation, the medium
was replaced with 100 ml fresh DMEM and 20 ml of 5 mgmL21
MTT and was further incubated for one hour. Subsequently, the
cell medium was aspirated and 100 ml of 100% DMSO was added
to all wells to dissolve the insoluble purple formazan product into a
colored solution; the absorbance of which was measured at a
wavelength of 570 nm using a microplate reader (Hidex
Chameleon, Finland). The optical density (OD) of the samples
was compared to that of the negative control to obtain the
percentage viability as follows: Cell viability (%) = [(OD 570
(sample)/OD570 (negative control))6100].
TNF production
RAW 264.7 were seeded in 96-well plates at 56105cellsmL21
and pre-treated with AA or pentoxifilline at the indicated
concentrations, or left untreated for 30 minutes. The cells were
then stimulated with 1 mgmL21 LPS for 4 hours [16]. The cell
supernatant was stored at 280uC until analysis. TNF quantifica-
tion was done using mouse TNF-a ELISA kit according to the
manufacturer’s protocol (eBioscience, USA).
Cytokines measurement
Multiplex cytokine assay. The Procarta cytokine profiling
kit and the Quantigene Plex 2.0 reagent system for mRNA
analysis [17], both from Panomics (Affymetrix, USA), were used to
measure five cytokines in the mouse inflammatory panel:
interleukin 1b (IL-1b), interleukin 6 (IL-6), Chemokine (C-X-C
motif) ligand 1 (CXCL-1 or KC), granulocyte monocyte colony
stimulating factor (GM-CSF), and TNF in the cell culture
supernatants and cultured cells. Although IL-8 is an important
proinflammatory chemokine in the human inflammatory response
[18], this chemokine is not produced by murine cells. However,
the cytokine KC (CXCL-1) which was tested in this study is a
murine cytokine functionally homologous to the human IL-8
[19,20]. The multiplex cytokine assay uses xMAP technology
(multi-analyte profiling Luminex technology) to enable the
detection and quantification of multiple protein targets
simultaneously. RAW 264.7 were seeded in 96-well plates at
56105cellsmL21 and pre-treated with AA or pentoxifilline at the
indicated concentrations, or left untreated for 30 minutes. The
cells were then stimulated with 1 mgmL21 LPS for 4 hours. The
cell supernatant and the cells were stored separately at 280uC
until analysis. The samples were processed according to the
manufacturer’s protocol. For the protein quantification assays,
MasterPlex QT4.0 software was used to analyze the concentration
of each cytokine in each sample from the arbitrary unit median
fluorescence intensity (MFI). The percentage inhibition was then
calculated as follows:
% Inhibition
~100 X cytokine½ control  ½cytokinesampleÞ= cytokine½ control
 
:

For the Quantigene Plex 2.0 assay, MFI was normalized to the
house keeping gene GADPH, and the calculation of the fold-
change percentage inhibition was calculated as the formula above,
with the replacement of cytokine concentration values with the
fold change in expression.
Nitrite Determination and iNOS activation
Nitrite measurement. Tests were prepared as in [21] with
some modifications. RAW 264.7 were seeded in 96-well plates at
56105cellsmL21 for 2 hours in DMEM without phenol red. The
cells were stimulated with IFN-c and LPS with final concen-
trations of 200 UmL21 and 10 mgmL21, respectively. Stimulated
cells were either treated with AA at different concentrations
(1.2520.125 mgmL21) or were treated with the iNOS inhibitor
aminoguanidine at 1 mM as a positive control; or were left
untreated (negative control). The final volume per well was 100 ml.
The plates were then incubated for 16–20 hrs at 37uC, 5% CO2.
Following incubation, the inhibition of nitric oxide (NO) release
was assessed by quantifying nitrite (NO2
2), one of the final
products of NO oxidation, in the cell supernatant by utilizing the
Griess reaction [22]. The resulting color development was mea-
sured at 550 nm with a microplate reader Tecan Sunrise (Gro¨dig,
Austria). The absorbance values were compared to a standard
sodium nitrite curve and the absorbance values were converted to
corresponding nitrite concentrations (mM). The percentages of NO
inhibition were calculated as follows:
% Inhibition
~100 X NO2{½ control{ NO2{½ sample
 
= NO2{½ control
h i
Inducible nitric oxide synthase (iNOS) activation assay.
Murine RAW264.7 cells were seeded overnight in 96-well plates at
a density of 2.56105 cells mL21. The cells were pre-treated with
either 1 mM aminoguanidine, different concentrations of AA or
were left untreated, for 30 minutes. The cells were then stimulated
with IFN-c and LPS (200 UmL21 and 1 mgmL21) for 18 hours,
and the inhibition of iNOS induction in the cells was quantitatively
assayed using CellomicsH iNOS activation kit according to the
manufacturer’s instructions. The assay plate was evaluated on
ArrayScan HCS Reader instrument from Cellomics (Pittsburg,
USA). The Cytoplasm to Nucleus Translocation BioApplication
software was used to calculate the intensity of cytoplasmic iNOS
intensity. The average intensity of 200 objects (cells) per well was
quantified and percentage inhibition was calculated by comparing
the various groups’ cytoplasmic intensities to that of LPS and IFNc
stimulated cells.
NF-kB Translocation assay
Murine RAW264.7 or L929 cells were seeded overnight at 1.2 or
2.56105 cellsmL21; respectively, in a 96-well plate. The cells were
either pre-treated for one hour with different concentrations of AA
or were left untreated. RAW264.7 cells were then stimulated with
10 ngmL21 of LPS; whereas L929 cells were stimulated with
1 ngmL21 TNF, both for 30 minutes. The medium was discarded
and cells were fixed and stained using CellomicsH NF-kB activation
kit from Thermo Scientific according to the manufacturer’s
instructions. The assay plate was evaluated on ArrayScan HCS
Reader. The Cytoplasm to Nucleus Translocation BioApplication
software was used to calculate the ratio of cytoplasmic and nuclear
NF-kB intensity [23]. The average intensity of 200 objects (cells) per
well was quantified. The ratios were then compared among
stimulated, treated, and untreated cells.
Inhibitor of NF-kB Kinase beta (IKKb) activity assay
The effect of AA on IKKb activity was evaluated using K-
LISATM IKKb-Inhibitor Screening Kit from Calbiochem, Merck
(Darmstadt, Germany), according to the manufacturer’s protocol.
Anti-Inflammatory Activity of Acetylacuminolide
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AA (3.1–50 mgmL21) was incubated with the GST-IkBa substrate
and IKKb in the wells of a Glutathione-coated 96-well plate. The
phosphorylated GST-IkBa substrate was detected using an Anti-
Phospho IkBa (Ser32/Ser36) antibody, followed by the HRP-
Conjugate and color development with TMB Substrate. ELISA
Stop Solution was used to stop the color development and the
absorbance was read at 450 nm. Absorbance was directly related
to the level of IKKb activity from which percentage inhibitions
were calculated.
Animals
Male Balb/c mice (5–6 weeks of age) were maintained under
pathogen-free conditions in the animal housing unit in a temperature-
controlled (2362uC) and light-controlled (12-h light/dark cycle)
room. The animals were provided standard rodent chow and water
ad libitum.
Measurement of in vivo serum TNF
The mice were divided into 4 groups: no treatment group,
injected with phosphate buffered saline (PBS); LPS only; LPS+
Dexamethasone (6 mgkg21); or LPS+AA (100 mgkg21) (n = 9–10
for each group). Groups were pretreated intraperitoneally (i.p.) with
200 ml of PBS, Dexamethasone or AA for 30 minutes. Lipopoly-
saccharide (1 mgkg21) was then administered in 200 ml i.p for three
treatment groups, and PBS was administered i.p. for the negative
control group. Blood was withdrawn from the animals under ether
anesthesia ninety minutes later [24]. Blood from mice was
centrifuged at 2000 rpm for 10 minutes, and the serum was
collected and stored at280uC until analysis. Serum levels of TNF-a
were determined using Mouse TNF-a ELISA kit (eBioscience,
USA).
Statistical Analyses
The assays were conducted in at least three separate experi-
ments, unless otherwise specified. Data are expressed as the mean
6 standard deviation. Data were analyzed using Graph pad prism
statistical software (version 4; GraphPad Software Inc., La Jolla,
California) for one-way analysis of variance (ANOVA) with
Tukey’s post hoc test, or Student’s t-test as indicated. Differences
were considered significant at p,0.05. The half maximal
inhibitory concentration (IC50) was calculated using sigmoidal
dose-response (variable slope) equation under non-linear regres-
sion (curve fit) utilizing the same software. Where inhibition is
calculated; values from untreated, unstimulated cells were con-
sidered as the maximum inhibition (100%).
Results
17-O-acetylacuminolide is a major component of
Neouvaria foetida
Neouvaria foetida methanol extract exhibited effective inhibition of
TNF release from LPS stimulated RAW264.7 macrophages in a
preliminary screen of more than 300 Malaysian plant extracts.
Bio-assay guided fractionation lead to the isolation of two active
compounds which were identified as acuminolide and 17-O-
acetylacuminolide by MS and 1H-NMR. Both compounds have
previously been isolated from a different species of Neouvaria,
namely Neouvaria acuminatissima (Miq) [14]. Upon recrystallization
in methanol, 17-O-acetylacuminolide formed as colorless needles
(98 mg, 0.0196% dry wt/wt, .98.5% purity by HPLC). Due to
acuminolide’s reported in vivo toxicity [14], the present study was
confined to investigating the anti-inflammatory activities of AA,
which even at 110 mg/kg did not seem to have any in vivo toxic
effect [14].
Cell viability and cytotoxicity
The effect of AA on cell viability was evaluated using the MTT
assay. As depicted in Figure 2, following a 4 h treatment, AA had no
effect on RAW264.7 cell viability with concentrations ranging from
0.01–5 mgmL21. However, the highest dose tested (50 mgmL21)
resulted in a 50% decrease in viability. Therefore for prolonged
assays (.4 h), the pharmacological effects of this compound were
Figure 2. The effect of 17-O-acetylacuminolide (AA) on cell viability in RAW264.7 cells. Cells were pretreated with the indicated doses of
AA for 4 hours or were left untreated (DMEM). Data is the average of three independent experiments (6SD), and was analyzed using one way ANOVA
with Tukey’s post test (** p,0.01, *** p,0.001).
doi:10.1371/journal.pone.0015105.g002
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assessed at lower, non-cytotoxic concentrations. An exception was
the NF-kB translocation assay where high doses were used since the
assay duration was short, and no significant toxicity was observed up
to 40 mgmL21.
17-O-Acetylacuminolide inhibits TNF production
Stimulation of RAW264.7 with LPS for 4 hours caused a
significant increase in TNF production. In the enzyme-linked
immunoassay, AA effectively inhibited TNF-a release with an IC50
of 2.7 mgmL21. As shown in Figure 3, AA dose-dependently and
significantly suppressed TNF production in RAW264.7 cell
supernatant at non-cytotoxic doses ranging from 5–0.01 mgmL21.
Effects of 17-O-Acetylacuminolide on inflammatory
cytokines production and expression
LPS is known to activate the transcription process of various
inflammatory mediators and cytokines [11]. Table 1 presents a
summary of the effects of LPS stimulation in RAW264.7 cells.
There was a significant release of all five cytokines in the
supernatant. Also, there was a significant production of TNF, IL-
1b, IL-6 and KC but not GM-CSF in the cell lysates (intracellular
protein). At the transcription level, four hours of LPS treatment at
1 mgmL21 significantly induced the transcription of TNF and IL-
1b mRNA, but not IL-6, CXCL-1 (KC), or CSF-2 (GM-CSF).
In this multiplex assay, AA was tested for its ability to inhibit
TNF, IL-1b, IL-6, KC (CXCL-1), and GM-CSF both at the
protein production level and at the transcription level. Figure 4 (A)
depicts the percentage inhibition of cytokines released into the
supernatant of cell samples pretreated with AA as compared to
cells treated with LPS alone (LPS). AA demonstrated a dose-
dependent pattern of inhibition for almost all cytokines tested.
Moreover, AA significantly and dose-dependently reduced intra-
cellular increase of four pro-inflammatory cytokines in LPS treated
samples as seen in Figure 4 (B). However, AA did not affect
GM-CSF concentrations, presumably because there was no
difference in this cytokine’s concentration between LPS-stimulated
and untreated cells (Table 1), this is in accordance with a previous
report in which GM-CSF concentrations of cell lysates was less
than 40% that of the corresponding supernatants [25].
At the transcription level (Figure 5), AA seemed to inhibit TNF
and IL-1b, both of which were up-regulated significantly by LPS
stimulation. The compound did not seem to affect the transcrip-
tion of the 3 other cytokines tested. Although LPS stimulation
seemed to increase the mRNA for IL-6, CXCL-1 and CSF-2; the
mRNA levels for these 3 genes were not significantly different from
the untreated cells (Table 1).
Nitrite Determination and iNOS activation
Stimulation with LPS and IFN-c led to a fifty six-fold increase in
nitrite concentrations in the cell supernatant with a concentration
of 157 mM as compared to the basal level of 2.75 mM in untreated
cells. NO release was effectively inhibited by AA with an IC50 of
0.62 mgmL21. Following 20 hours of treatment and stimulation,
AA caused a 78.9% inhibition of NO at 1.25 mgmL21, without
affecting the cell viability (Figure 6).
Treatment of RAW264.7 cells with LPS and IFNc lead to a 2.45-
fold increase in iNOS protein expression in the cytoplasm. The
increase in intensity of this inducible protein in the cytoplasm is
directly related to its expression in the cell (Figure 7). AA suppressed
the up-regulation of the inducible form of the nitric oxide synthase
enzyme (iNOS). The same pattern of NO inhibition was observed in
that for iNOS inhibition by AA. Percentage inhibition was
calculated by comparing the change in average intensity between
groups of cells, where LPS and IFN-treated group of cells was
considered as zero percent inhibition, (control) in Figure 8. At
1.25 mgmL21, AA caused ,60% inhibition of iNOS expression
whereas the lowest concentration of AA (0.126 mgmL21) tested
conferred an almost similar inhibition as that of the iNOS inhibitor
Figure 3. The inhibitory effect of 17-O-acetylacuminolide (AA) on TNF production in RAW264.7 cells. Cells were pretreated with the
indicated doses of AA, or the TNF inhibitor pentoxifylline (PTX). The cells were stimulated with LPS (1 mgmL21) for four hours, or were left untreated
(DMEM).The protein concentration was measured using ELISA. Data is representative of three independent experiments, and was analyzed using one
way ANOVA with Tukey’s post hoc test (** p,0.01, *** p,0.001).
doi:10.1371/journal.pone.0015105.g003
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aminoguanidine (AG); 22% and 25% inhibition, respectively. The
calculated EC50 for AA iNOS inhibition was estimated at
0.96 mgmL21.
17-O-acetylacuminolide inhibits NF-kB Translocation
The ability of AA to inhibit the transcription factor NF-kB was
investigated. Treatment of L929 fibroblasts with TNF (1 ngmL21)
for 30 minutes lead to a 2.2-fold increase in the cytoplasm:nucleus
NF-kB ratio (Figure 9). Whereas treatment of RAW264.7 cells
with 10 ngmL21 LPS for 30 minutes lead to a 1.6-fold increase as
compared to untreated cells (Figure 10). Pretreatment of
stimulated cells with AA inhibited the translocation of NF-kB to
the nucleus in both TNF-stimulated and LPS-stimulated cells in a
dose-dependent manner (Figure 11).
17-O-Acetylacuminolide inhibits IKKb activity
As can be seen in Figure 12, AA significantly inhibited the
activity of IKKb, with a maximum inhibition of 68% at the
highest concentration tested (50 mgmL21).
17-O-Acetylacuminolide decreases serum TNF in LPS-
stimulated Balb/c mice
Injecting mice with LPS lead to .3000-fold increase in serum
TNF levels compared to untreated mice. AA significantly reduced
the serum TNF level by 35% in the LPS-stimulated animals
(Figure 13). Pretreatment with the anti-inflammatory steroid
dexamethasone caused a 54% reduction in serum TNF in LPS-
stimulated mice.
Discussion
In an effort to search for novel anti-inflammatory agents from
Malaysian plants, more than 300 plant extracts were tested for
their ability to reduce TNF production from LPS-stimulated
RAW264.7 macrophages. The methanol extract of Neouvaria foetida
leaves exhibited effective inhibition of TNF release; this conse-
quently led to the identification of two active compounds
acuminolide and 17-O-acetylacuminolide as being responsible for
the observed activity. Although both acuminolide and 17-O-
acetylacuminolide were isolated previously [14], to the best of our
knowledge this is the first time their isolation from the species
Neouvaria foetida is reported. Moreover, this is the first time the
compounds were shown to reduce TNF production. TNF-a plays
a pivotal role in several inflammatory conditions [26]. In order to
evaluate the compound’s activity, we further examined the anti-
inflammatory effects of this compound on other inflammatory
cytokines and mediators. TNF, IL1-b, IL-6, KC (CXCL-1) and
GM-CSF were all shown to be up-regulated by LPS treatment
[12], [27,28,29,30]. Amongst the cytokines notably produced by
LPS stimulation in this study, AA significantly reduced the
production of TNF and IL-1b at both the transcription and
translation levels. Upon stimulation with LPS, the various
inflammatory mediators such as cytokines, NO and chemokines
are induced at varying magnitudes and at different time points in
response to the same stimulus [12,17,31]. This could explain, at
least in part, the reason for lack of a significant difference in some
of the cytokine’s mRNA fold change between untreated and LPS-
stimulated cells, as is the case for IL-6, CXCL-1 and CSF-2
(Table 1), and hence the reason for the lack of capacity to assess
AA’s effect on these cytokine genes.
Although AA significantly and dose-dependently reduced TNF
production with a concentration as low as 10 ngmL21 in the
ELISA assay, the inhibition was not significant for the lowest dose
(6.25 mgmL21) tested in the Procarta multiplex cytokine assay.
However, the pattern of inhibition was still present in the latter
assay. This may be due to the different methods used [32], as the
Procarta cytokines assay is based on multiplexed measurement of
fluorescence beads, whereas the ELISA method is a solid phase
and TNF specific assay. It had been reported that using kits from
various manufacturers for cytokines measurement yielded similar
patterns, but different absolute concentrations [33].
Nitric oxide plays an important role in various inflammatory
conditions where it is produced by the inducible form of nitric
oxide synthase (iNOS) [34]. LPS and IFN-c were shown to induce
the expression of this enzyme, resulting in the production of
abundant amounts of NO [35]. In addition to down-regulating
several inflammatory cytokines, AA dose-dependently inhibited
the production of nitric oxide. Moreover, the compound seemed
to inhibit the expression of the enzyme responsible for the
production of this inflammatory mediator (figures 7 and 8).
Table 1. Comparing protein concentrations and gene expression of 5 pro-inflammatory cytokines in untreated cells and
stimulated cells.
Sample
Protein Conc. Supernatant
(pgmL21) (±STDEV) P value
Protein Conc. Lysate
(pgmL21) (±STDEV) P value
Normalized mRNA
(fold-change) (±STDEV) P value
TNF Stim. 2510.71 (6708.32) ** 122.31 (641.03) ** 41.54 (613.64) **
DMEM 17.17 (63.88) 2.01 (60.32) 2.14 (60.57)
IL-1b Stim. 212.06 (628.49) *** 21.28 (66.22) ** 39.80 (614.57) **
DMEM 6.68 (64.73) 3.08 (60.00) 0.15 (60.08)
IL-6 Stim. 60.64 (64.37) *** 0.75 (60.18) * 0.61 (60.39) ns
DMEM 1.22 (60.00) 0.06 (60.00) 0.25 (60.19)
KC/CXCL-1 Stim. 21.81 (63.17) *** 1.43 (60.43) ** 46.82 (626.00) ns
DMEM 1.22 (60.00) 0.25 (60.00) 28.07 (622.99)
GMCSF/CSF-2 Stim. 38.46 (64.49) *** 5.16 (60.39) Ns 25.07 (613.43) ns
DMEM 1.42 (60.35) 4.41 (60.99) 13.80 (611.14)
Cells were either left untreated in medium (DMEM), or were stimulated with 1 mgmL21 LPS (Stim.) for four hours (stimulated). The table provides a comparison in
protein concentrations (Protein Conc.) in the cell supernatant and lysates, as well as differences in gene expression. Student’s t-test was used to calculate the statistical
significance between the two groups (ns: not significant, * p,0.05, ** p,0.01, *** p,0.001).
doi:10.1371/journal.pone.0015105.t001
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The inducible transcription factor NF-kB is responsible for the
regulation of a plethora of genes involved in carcinogenesis and
inflammation [4]. Due to the fact that the production of both
iNOS [36] and pro-inflammatory cytokines and mediators [37]
are regulated, at least in part, by the transcription factor NF-kB,
we investigated the role AA plays on inhibiting this transcription
factor’s translocation. LPS as well as TNF were shown to cause
NF-kB activation in RAW264.7 [38] and L929 cells [39],
Figure 4. The inhibitory effect of 17-O-acetylacuminolide (AA) on cytokine release and synthesis in RAW264.7 cells. Cells were
pretreated with the indicated doses of AA. The cells were stimulated with LPS (1 mgmL21) for 4 hrs, or were left untreated (DMEM). Supernatant (A)
and intracellular (B) protein concentrations were measured using Procarta 5-plex cytokine profiling kit from which inhibitions were calculated. Data
is representative of three independent experiments, and was analyzed using one-way ANOVA with Tukey’s post hoc test (* p,0.05, ** p,0.01,
*** p,0.001).
doi:10.1371/journal.pone.0015105.g004
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Figure 5. The inhibitory effect of 17-O-acetylacuminolide (AA) on cytokine mRNA. Cells were treated and mRNA was quantified as
described in materials and methods. Data presented is of AA inhibition of TNF and IL-1b mRNA induction and is representative of three independent
experiments. Data was analyzed using one-way ANOVA with Tukey’s post hoc test (*** p,0.001).
doi:10.1371/journal.pone.0015105.g005
Figure 6. Percentage inhibition of nitric oxide (NO) in RAW264.7. Cells were pretreated with the indicated doses of 17-O-acetylacuminolide
(AA) or with 1 mM of the iNOS inhibitor Aminoguanidine (AG). The cells were stimulated with LPS and IFNc to activate iNOS synthesis, and eventually
NO release. Data presented is the percentage of NO inhibition compared to untreated (DMEM), stimulated cells (control). Data is the average of three
independent experiments (6SD), and was analyzed using one way ANOVA with Tukey’s post test (* p,0.05, ** p,0.01, *** p,0.001).
doi:10.1371/journal.pone.0015105.g006
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Figure 7. Effect of AA on iNOS expression in RAW264.7 cells. In untreated cells, the nuclei of the cells appear green (hoescht) and iNOS
expression was undetected (DMEM). iNOS (DyLightTM 488, magenta), was expressed in the cell cytoplasm of stimulated cells. Pretreatment with
aminoguanidine (AG) or 17-O-acetylacuminolide (AA) was able to inhibit iNOS expression in cells stimulated with lipopolysaccharide and interferon
gamma (LPS+IFNc).
doi:10.1371/journal.pone.0015105.g007
Figure 8. Percentage inhibition of inducible nitric oxide synthase (iNOS) in RAW264.7. Cells were pretreated with the indicated doses of
AA or with 1 mM of the iNOS inhibitor Aminoguanidine (AG). The cells were stimulated with LPS and IFNc to activate iNOS. Data presented is the
percentage of iNOS inhibition compared to untreated, stimulated cells (control), and is the average of two experiments. Data was analyzed using one
way ANOVA and Tukey’s post hoc analysis (* p,0.05, ** p,0.01). Cell count was unaffected at the doses tested (data not shown).
doi:10.1371/journal.pone.0015105.g008
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respectively. AA was able to inhibit the translocation of NF-kB in
both LPS-treated RAW264.7 cells and TNF-treated L929 cells.
This suggests that AA acts via a post-receptor signaling
mechanism, since the pro-inflammatory stimulators used, i.e.
LPS and TNF, act on different receptors, Toll like receptor 4
(TLR4) [40] and TNF receptor [41], respectively. The activation
of NF-kB converges at the inhibitor of kappa B kinase (IKK)
complex [42]. In the cell cytoplasm, NF-kB is sequestered by the
inhibitor of kappa B (IkBa) protein [43]. The IKK complex
phosphorylates IkBa protein upon activation by pro-inflammatory
stimulators (e.g. TNF, LPS, IL-1b) [44]. This in turn leads to the
activation of NF-kB and its translocation to the nucleus [45]. AA
significantly inhibited the activity of IKKb, which, along with
IKKa comprise the catalytic part of the IKK complex [46].
Therefore, the inhibition of the IKK complex points to a possible
mechanism of action by which AA inhibits NF-kB translocation
and exerts its anti-inflammatory effects.
It was shown previously [14] that AA had potential in vitro
activity against prostate (LNCaP) and melanoma (Mel2) cancer
cell lines. The inactivation of NF-kB activity in these cell lines was
shown to cause apoptosis [47] and [48]. Since AA was shown to
inhibit NF-kB translocation, the cytotoxic effects of this compound
may be attributed, to a certain extent, to the inhibition of this
transcription factor.
Having demonstrated that AA possesses anti-inflammatory
activity in vitro, we next tested it in an in vivo model of
inflammation. In this model of in vivo acute inflammation [24],
TNF release in mice serum dropped markedly upon pretreatment
with AA. It has been demonstrated that several natural product
compounds which fall under the class of terpenoids act as strong
Figure 9. Effect of AA on TNF-stimulated L929 cells. NF-kB (DylightTM488, light blue); was sequestered in the cytoplasm of cells treated with
media only (DMEM), the nuclei of the cells appear red (Hoescht). Upon TNF stimulation (TNF), NF-kB translocated to the nucleus. Pretreatment with
curcumin (curc.), or 17-O-acetylacuminolide (AA) was able to prevent NF-kB translocation in the presence of TNF. (AA IC50 = 10.9 mgmL
21).
doi:10.1371/journal.pone.0015105.g009
Figure 10. Effect of AA on LPS-stimulated RAW264.7 cells. NF-kB (DyLightTM 488, light green), was sequestered in the cytoplasm in cells
treated with DMEM alone (untreated), and the nuclei of the cells appear blue (Hoescht). However, NF-kB translocates into the nucleus upon LPS
stimulation. Pretreatment with 17-O-acetylacuminolide (AA) was able to prevent NF-kB translocation in the presence of LPS (IC50 = 7.8 mgmL
21).
doi:10.1371/journal.pone.0015105.g010
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Figure 11. The inhibitory effect of 17-O-acetylacuminolide (AA) on the increase of nuclear NF-kB intensity. Cells were pretreated with
the indicated doses of AA or with 0.1 mM of the NF-kB inhibitor Curcumin (Curc). L929 cells were stimulated with TNF (1 ngmL21), whereas
RAW264.7 cells were stimulated with LPS (10 ngml21) to cause NF-kB translocation to the nucleus, or were left untreated (DMEM). Data is the average
of three independent experiments (6SD), and was analyzed using one way ANOVA with Tukey’s post test. The effect was considered significant when
groups were compared to TNF (#) or LPS (*) treated L929 and RAW264.7 cells, respectively. (# p,0.05, ** p,0.01, ###, *** p,0.001).
doi:10.1371/journal.pone.0015105.g011
Figure 12. Effects of 17-O-acetylacuminolide (AA) on IKKb
activity. Human, recombinant IKKb (5 ng) was incubated in the pre-
sence of increasing concentrations of AA as outlined in the
manufacturer’s detailed protocol. AA dose-dependently inhibited IKKb
activity with an EC50 of 5.2 mgmL
21. Results are average of three
independent experiments 6SD. Data was analyzed using one-way
ANOVA, with Tukey’s post hoc test (* p,0.05, ** p,0.01, *** p,0.001).
doi:10.1371/journal.pone.0015105.g012
Figure 13. Effect of 17-O-acetylacuminolide (AA) on serum TNF
levels in mice. Mice were pretreated i.p. with either 100 mgkg21 of
AA, 6 mgkg21 of dexamethasone (DEX) or with Phosphate buffer saline
(PBS) and DMSO (untreated) for 30 mins. The mice were then either
injected with 1 mgkg21 lipopolysaccharide (LPS) or with PBS for
90 mins. Blood was withdrawn, and serum TNF was quantified using
ELISA. One way ANOVA with Tukey’s post analysis was used to calculate
the statistical significance among the groups when compared to
PBS+LPS group; *** p,0.001.
doi:10.1371/journal.pone.0015105.g013
Anti-Inflammatory Activity of Acetylacuminolide
PLoS ONE | www.plosone.org 11 December 2010 | Volume 5 | Issue 12 | e15105
inhibitors of NF-kB activation [13]. Bearing in mind that 17-O-
acetylacuminolide is a diterpene labdane, it is no surprise that this
compound possesses potent anti-inflammatory activity as described
in this study, as well as cytotoxic activity as described in [14]. This
summarizes the potential value of 17-O-acetylacuminolide as a
lead compound for the development of an anti-cancer or an anti-
inflammatory drug, and warrants further testing of this compound
in human cells models of inflammation.
Supporting Information
Figure S1 Chromatogram of Neouvaria foetidamethano-
lic extract. HPLC chromatogram of the crude extract, arrows
indicate the peaks of acuminolide (1) and 17-O-acetylacuminolide (2).
(TIF)
Figure S2 1H NMR spectrum of 17-O-acetylacuminolide
(2) in CDCl3.
(TIF)
Figure S3 TIC mass chromatogram of 17-O-acetylacu-
minolide (2).
(TIF)
Figure S4 Mass spectra of 17-O-acetylacuminolide (2).
The spectra are a result of negative ionization mass spectrometry
(MS21) and tandem spectrometry (MS/MS)
(TIF)
Figure S5 UV chromatogram of 17-O-acetylacuminolide
(2).
(TIF)
Figure S6 Extracted UV Spectrum of 17-O-acetylacumi-
nolide (2).
(TIF)
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